Moogene Medi Co., Ltd.

A322970

KR7322970005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
2,090 ^KRW	+4.50%		-4.57%	-24.41%

2023	Moogene Medi Co., Ltd. announced that it has received KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	CI
2023	Moogene Medi Co., Ltd. announced that it expects to receive KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	CI

Moogene Medi Co., Ltd. announced that it has received KRW 6.999994554 billion in funding from Pion-Tech Co., Ltd.

July 17, 2023

On July 18, 2023, Moogene Medi Co., Ltd closed the transaction. The company has issued 2,109,703 common shares at an issue price of KRW 3,318 for the gross proceeds of KRW 6,999,994,554.

Latest news about Moogene Medi Co., Ltd.

Moogene Medi Co., Ltd. announced that it has received KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	Dec. 14	CI
Moogene Medi Co., Ltd. announced that it expects to receive KRW 3.4999974 billion in funding from Miracle & Partners Co., Ltd., Belight Investment	Dec. 06	CI
Moogene Medi Co., Ltd. announced that it has received KRW 6.999994554 billion in funding from Pion-Tech Co., Ltd.	23-07-17	CI
Moogene Medi Co., Ltd. announced that it expects to receive KRW 7.999993302 billion in funding from Pion-Tech Co., Ltd. and other investors	23-07-02	CI
Moogene Medi Co., Ltd. announced that it has received KRW 300 million in funding from MAGELLAN Technology Investment, Co., Ltd.	22-04-14	CI
Moogene Medi Co., Ltd. announced that it expects to receive KRW 300 million in funding from MAGELLAN Technology Investment, Co., Ltd.	22-04-06	CI

Moogene medi Co Ltd is a Korea-based company mainly engaged in the research and development of biological and chemical agents capable of treating incurable diseases. The Company mainly manufactures and sells medicines such as treatments of colorectal cancer, treatments for hair loss, and treatments for diabetes.

Sector

Biotechnology & Medical Research

Calendar

2024-06-24 - Investor Meeting

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MOOGENE MEDI CO., LTD.	-24.41%	15.13M
MODERNA, INC.	+40.80%	53.67B
LONZA GROUP AG	+35.79%	38.86B
IQVIA HOLDINGS INC.	-8.05%	38.76B
CELLTRION, INC.	-8.98%	27.27B
ICON PUBLIC LIMITED COMPANY	+10.69%	25.91B
ALNYLAM PHARMACEUTICALS, INC.	-16.21%	20.29B
UNITED THERAPEUTICS CORPORATION	+31.00%	12.78B
MEDPACE HOLDINGS, INC.	+28.51%	12.18B
BIO-TECHNE CORPORATION	-1.67%	11.96B

Other Biotechnology & Medical Research